Release Date: 22/01/21 08:44 Summary: Appendix 4C - quarterly Price Sensitive: Yes Download Document 170.29KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%